PPARγ activation prevents cardiac insufficiency by inhibiting apoptosis and necrosis [33], and by regulating PPARγ expression, it induces Bcl-2, Bax, and cytochrome-c expression changes and attenuates cardiomyocyte apoptosis [34]. The gene discussed is BCL2; the disease is heart failure.